HPV (Human Papilloma Virus) immunization
HPV Vaccine is Cancer PREVENTION
Every year over 37,000 Americans get cancer caused by HPV infection. HPV vaccine is recommended for girls and boys starting at age 9, in order to provide the best protection against HPV infection and HPV cancers.
Statistics and recommendations updated from the Centers for Disease Control and Prevention (2018)
Schedule an appointment
Know more about the HPV vaccine
About 13 million people, including teens, become infected with human papilloma virus (HPV) each year.
- Dose 1 (age 9-14 years)
- Dose 2 (at least 6 months after Dose 1)
Children who start their vaccine series at age 15 years and older need to get three
doses of the vaccine.
- Dose 1 (age 15+ years)
- Dose 2 (1-2 months after Dose 1)
- Dose 3 (At least 6 months after Dose 1)
All vaccines used in the U.S. are well tested for safety before they are approved and licensed by the Food and Drug Administration (FDA). Once in use, they are regularly checked to make sure they are safe and effective. The HPV Vaccine is approved by the FDA and is recommended by the CDC to prevent HPV infections and HPV related cancers. The vaccine was tested to make sure it was safe, both before and after the vaccine was licensed in 2006. Since then, no safety concerns have been found in the large studies. The CDC and FDA have looked at the study information for the vaccine and have declared it safe. The HPV vaccine is made from a single protein from the HPV virus that is not infectious or carcinogenic. This means it cannot cause HPV infection or cancer; it prevents them.
Statistics and recommendations updated from the Centers for Disease Control and Prevention (2018)